5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.93%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
4.57%
Gross profit growth above 1.5x STERV.HE's 0.99%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
29.21%
EBIT growth similar to STERV.HE's 31.71%. Walter Schloss might infer both firms share similar operational efficiencies.
29.21%
Operating income growth similar to STERV.HE's 31.71%. Walter Schloss would assume both share comparable operational structures.
12.29%
Net income growth under 50% of STERV.HE's 30.82%. Michael Burry would suspect the firm is falling well behind a key competitor.
22.22%
EPS growth at 75-90% of STERV.HE's 26.32%. Bill Ackman would push for improved profitability or share repurchases to catch up.
22.22%
Diluted EPS growth at 75-90% of STERV.HE's 26.32%. Bill Ackman would expect further improvements in net income or share count reduction.
-8.13%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.13%
Reduced diluted shares while STERV.HE is at 0.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
81.94%
OCF growth above 1.5x STERV.HE's 28.62%. David Dodd would confirm a clear edge in underlying cash generation.
141.37%
FCF growth above 1.5x STERV.HE's 45.81%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-31.36%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-37.05%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-6.92%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-10.70%
Negative 10Y OCF/share CAGR while STERV.HE stands at 16.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
38.92%
5Y OCF/share CAGR at 50-75% of STERV.HE's 63.52%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
31.48%
3Y OCF/share CAGR under 50% of STERV.HE's 93.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
145.83%
Similar net income/share CAGR to STERV.HE's 143.41%. Walter Schloss would see parallel tailwinds or expansions for both firms.
243.75%
5Y net income/share CAGR above 1.5x STERV.HE's 138.75%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
88.80%
3Y net income/share CAGR above 1.5x STERV.HE's 54.03%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-5.23%
Negative 5Y equity/share growth while STERV.HE is at 1.12%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
30.35%
3Y equity/share CAGR above 1.5x STERV.HE's 10.65%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.94%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.32%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.14%
Positive asset growth while STERV.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
11.35%
BV/share growth above 1.5x STERV.HE's 3.27%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.70%
We have some new debt while STERV.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-8.90%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.